Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06135610 · ClinicalTrials.gov registry record
Social Determinants of Health in Patients With Penetrating Trauma Injuries Before and During the COVID-19 Pandemic
A clinical trial of COVID-19 and Social Determinants of Health, sponsored by Kern Medical Center.
- Completed
- Registry status
- 803
- Enrollment target
- 1
- Study location
NCT06135610 is a study of COVID-19 and Social Determinants of Health that has completed, run by Kern Medical Center. The registered enrollment target is 803 participants, below the 55,211-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06135610, a study of COVID-19 and Social Determinants of Health, has completed, sponsored by Kern Medical Center.
- COMPLETED
- Registry status
- 803 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators report on the impact of the COVID-19 stay-at-home order concerning penetrating violence and its association within different socioeconomic regions within the county. The distribution and volume of violent offenses prior to the stay-at-home order was compared to during the stay-at-home order. This bears a crucial significance in our injury prevention and education efforts within our community.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Postive SAR-CoV-2 PCR nasopharyngeal swab
Study Locations (1)
California
- Kern Medical Center - Bakersfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 803 participants |
| Start Date | 2019-03-01 |
| Est. Completion | 2021-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06135610
The ClinicalTrials.gov registry entry for NCT06135610 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 803 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,211-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The listed sponsor is Kern Medical Center, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Postive SAR-CoV-2 PCR nasopharyngeal swab is the first listed.
NCT06135610 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06135610 about?
NCT06135610 is a clinical study titled "Social Determinants of Health in Patients With Penetrating Trauma Injuries Before and During the COVID-19 Pandemic". Investigators report on the impact of the COVID-19 stay-at-home order concerning penetrating violence and its association within different socioeconomic regions within the county. The distribution and volume of violent offenses prior to the stay-at-home order was compared to during the stay-at-home ...
What is the current status of trial NCT06135610?
This trial is currently completed. The enrollment target is 803 participants. The study started on 2019-03-01. Estimated completion is 2021-02-01.
What conditions does trial NCT06135610 study?
This clinical trial studies the following conditions: COVID-19, Social Determinants of Health, Penetrating Injury.
What interventions are being tested in trial NCT06135610?
The interventions under investigation include: Postive SAR-CoV-2 PCR nasopharyngeal swab (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06135610?
This trial is sponsored by Kern Medical Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06135610 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.